IMMUNOPHENOTYPING BY FLOW CYTOMETRY CD22 Test
At DNA Labs UAE, we offer the CD22 test, a type of immunophenotyping test performed using flow cytometry. This test is useful for identifying and characterizing B cells based on the expression of CD22, a cell surface protein primarily found on B cells.
Test Cost
The cost of the CD22 test is AED 480.0.
Test Components
- 3 mL (2 mL min.) whole blood in 1 Lavender Top (EDTA) tube
- 3 mL (2 mL min.) whole blood in 1 Green Top (Sodium Heparin) tube OR 2 mL (1 mL min.) Bone marrow in 1 Green Top (Sodium heparin) tube
Ship the samples immediately at 18°C–22°C. Do not refrigerate or freeze. Specify the time, date, and clinical details on the test request form.
Report Delivery
The sample is delivered daily by 9 am, and the report is available on the same day.
Method
The CD22 test is performed using flow cytometry, a specialized instrument that can analyze and sort cells based on their size, shape, and fluorescence.
Test Type
The CD22 test is used for cancer diagnosis, specifically in identifying and characterizing B cells.
Doctor
The CD22 test is usually requested by oncologists or hematologists.
Test Department
The CD22 test is performed in the FLOW CYTOMETRY department.
Pre Test Information
Please provide a brief clinical history when requesting the CD22 test.
Test Details
The CD22 test is a valuable tool in immunophenotyping. It involves collecting a sample of blood or bone marrow from the patient. The sample is then treated with fluorescently-labeled antibodies that specifically bind to CD22, allowing for the detection and quantification of CD22-positive B cells.
The sample is run through a flow cytometer, which uses laser beams to excite the fluorescently-labeled antibodies bound to CD22. The emitted light at specific wavelengths is detected by the instrument, generating a fluorescence profile for each cell. This allows for the identification and enumeration of CD22-positive B cells.
The results of the CD22 test provide valuable information about the B cell population in the patient’s sample. Abnormalities in CD22 expression patterns can indicate certain diseases, such as B-cell lymphomas or leukemias. The CD22 test can also be used to monitor the effectiveness of treatments targeting B cells, such as immunotherapies.
In summary, the CD22 test offered by DNA Labs UAE is a valuable tool in immunophenotyping, allowing for the identification and characterization of CD22-positive B cells using flow cytometry.
Test Name | IMMUNOPHENOTYPING BY FLOW CYTOMETRY CD22 Test |
---|---|
Components | |
Price | 480.0 AED |
Sample Condition | 3 mL (2 mL min.) whole blood in 1 Lavender Top (EDTA) tubeAND 3 mL (2 mL min.) whole blood in 1 Green Top (Sodium Heparin) tube OR 2 mL (1 mL min.) Bone marrow in 1 Green Top (Sodium heparin) tube. Ship immediately at 18\u0192??22?\u00f8C. DO NOT REFRIGERATE OR FREEZE. Specify time, date and clinical details on test request form. |
Report Delivery | Sample Daily by 9 am; Report Same day |
Method | Flow Cytometry |
Test type | Cancer |
Doctor | Oncologist, Hematologist |
Test Department: | FLOW CYTOMETRY |
Pre Test Information | Give brief clinical history. |
Test Details |
The CD22 test is a type of immunophenotyping test performed using flow cytometry. CD22 is a cell surface protein that is primarily expressed on B cells, making it a useful marker for identifying and characterizing these cells. During the test, a sample of blood or bone marrow is collected from the patient. The sample is then treated with fluorescently-labeled antibodies that specifically bind to CD22. These antibodies allow for the detection and quantification of CD22-positive B cells. The sample is then run through a flow cytometer, a specialized instrument that can analyze and sort cells based on their size, shape, and fluorescence. As the sample passes through the flow cytometer, laser beams excite the fluorescently-labeled antibodies bound to CD22, causing them to emit light at specific wavelengths. The instrument detects this emitted light and generates a fluorescence profile for each cell, allowing for the identification and enumeration of CD22-positive B cells. The results of the CD22 test can provide valuable information about the B cell population in the patient’s sample. Abnormalities in CD22 expression patterns can be indicative of certain diseases, such as B-cell lymphomas or leukemias. Additionally, the CD22 test can be used to monitor the effectiveness of treatments targeting B cells, such as immunotherapies. Overall, the CD22 test is a valuable tool in immunophenotyping, allowing for the identification and characterization of CD22-positive B cells using flow cytometry. |